MASH / NASH

Metabolic dysfunction-associated steatohepatitis (MASH), formerly called nonalcoholic steatohepatitis (NASH), is the inflammatory and fibrotic form of MASLD that can progress to cirrhosis, liver failure, and hepatocellular carcinoma.

Phase 1/2 and later readouts in MASH / NASH, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

Coverage in progress. AssetMemo has not yet run its full census for NASH Cirrhosis, so the assets listed for it are not complete.

Combined attributable cost

$32.0B+

Drug spend

Not yet sourced

How this is calculated ↗

Sum of 2 indications below.

All assets in MASH / NASH

← Gastroenterology & Hepatology